Skip to main content
Fig. 12 | Journal of Neuroinflammation

Fig. 12

From: Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis

Fig. 12

In demyelinating MS lesions, cells expressing SUR1 also express BAFF, CCL2, and NOS2. ac Immunolabeling for SUR1 (red) and BAFF (a), CCL2 (b), or NOS2 (c) (green) in chronic active white matter lesions; merged images are indicated; scale bars 100 μm. d Quantitative assessment using Pearson’s correlation coefficient (CC) of SUR1 co-localization with BAFF, CCL2, or NOS2; n = 5–7 lesions per labeling

Back to article page